MINNEAPOLIS (AP) — Medical device manufacturer Medtronic Inc. and French drugmaker Sanofi have joined in a project to develop new combinations of drugs and devices for diabetes care.
The two major companies announced Saturday the “global strategic alliance,” which they said was aimed at improving experience and results for people with diabetes around the world. The companies say the initial priorities will be developing drug-device combinations and providing care-management services to simplify insulin treatment.READ MORE: Minnesota Weather: Tornado Warnings Expire, But Severe Storms Still A Threat
Paris-based Sanofi has expertise in developing insulin drugs while Minneapolis-based Medtronic makes insulin pumps and devices for monitoring glucose to control blood sugar.READ MORE: Deputy Opens Fire During Struggle With Suspect Near Litchfield, Sheriff Says
According to the World Health Organization, an estimated 347 million people worldwide have diabetes. In the U.S., about 30 million people have the disease.MORE NEWS: 72-Year-Old Fargo Woman Killed In Douglas County Crash
(© Copyright 2014 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)